Neurocrine Biosciences Stock Forecast for 2023 - 2025 - 2030
Updated on 04/30/2024
Neurocrine Biosciences Stock Forecast and Price Target
Neurocrine Biosciences's stock is projected to advance by 12.69% from the previous closing price if it reaches the average target of $155.00 by the year's end, as six reputable analysts recently projected. This potential upside is calculated on a high-end estimate of $200.00 and a low-end estimate of $106.00. Even if you are not interested in NBIX stock, you should be aware of its competitors and their current standings.
12.69% Upside
Neurocrine Biosciences Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Neurocrine Biosciences's Price has decreased by 100.00%, from $379.44 to $0.00. For next year, analysts predict Fair Value of $557.61, which would mean an increase of 100.00%. Over the next seven years, experts predict that Neurocrine Biosciences's Fair Value will grow at a rate of 100.00%.
Neurocrine Biosciences Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Neurocrine Biosciences's Revenue has grown by 80.43%, rising from $1.05B to $1.89B. For next year, analysts predict Revenue of $2.10B, which would mean an increase of 11.45%. Over the next seven years, experts predict that Neurocrine Biosciences's Revenue will grow at a rate of 99.17%.
.jpg)
Neurocrine Biosciences EBITDA Forecast for 2023 - 2025 - 2030
Neurocrine Biosciences's EBITDA has grown In the last three years, rising from $336.10M to $416.10M – a growth of 23.80%. In the next year, analysts believe that EBITDA will reach $720.57M – an increase of 73.17%. For the next seven years, experts predict that Neurocrine Biosciences's EBITDA will grow at a rate of 546.43%.
Neurocrine Biosciences EBIT Forecast for 2023 - 2025 - 2030
Neurocrine Biosciences's EBIT has seen impressive growth In the last three years, rising from $327.50M to $394.80M – a growth of 20.55%. In the next year, analysts believe that EBIT will reach $623.96M – an increase of 58.04%. For the next seven years, the forecast is for EBIT to grow by 403.42%.
Neurocrine Biosciences EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Neurocrine Biosciences's EPS has decreased by 100.00%, from $4.11 to $0.00. For next year, analysts predict EPS of $6.04, which would mean an increase of 100.00%. Over the next seven years, experts predict that Neurocrine Biosciences's EPS will grow at a rate of 100.00%.
Site Navigation
.jpg)